These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 24342632)

  • 1. Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis.
    Hull CM; Levin MJ; Tyring SK; Spruance SL
    Antimicrob Agents Chemother; 2014; 58(3):1273-8. PubMed ID: 24342632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
    Hull CM; Brunton S
    Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of combination acyclovir 5% and hydrocortisone 1% cream in adolescents with recurrent herpes simplex labialis.
    Strand A; Böttiger D; Gever LN; Wheeler W
    Pediatr Dermatol; 2012; 29(1):105-10. PubMed ID: 22004219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.
    Evans TG; Bernstein DI; Raborn GW; Harmenberg J; Kowalski J; Spruance SL
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1870-4. PubMed ID: 12019102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
    Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
    Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
    JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.
    Nguyen HP; Stiegel KR; Downing C; Stiegel KR
    Skin Therapy Lett; 2014; 19(3):5-8. PubMed ID: 25188362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management and prevention of recurrent herpes labialis in immunocompetent patients.
    Gilbert SC
    Herpes; 2007 Dec; 14(3):56-61. PubMed ID: 18371287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on short-course intermittent and prevention therapies for herpes labialis.
    Gilbert S; Corey L; Cunningham A; Malkin JE; Stanberry L; Whitley R; Spruance S
    Herpes; 2007 Jun; 14 Suppl 1():13A-18A. PubMed ID: 17877887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection.
    McKeough MB; Spruance SL
    Arch Dermatol; 2001 Sep; 137(9):1153-8. PubMed ID: 11559210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Topical 5% Acyclovir-1% Hydrocortisone Cream (ME-609) for Treatment of Herpes Labialis: a systematic review.
    Rosa MI; Souza SL; Farias BF; Pires PD; Dondossola ER; dos Reis ME
    An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1415-20. PubMed ID: 26247156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of herpes simplex labialis.
    Spruance SL; Kriesel JD
    Herpes; 2002 Dec; 9(3):64-9. PubMed ID: 12470603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective treatment of herpes simplex labialis with penciclovir cream: combined results of two trials.
    Raborn GW; Martel AY; Lassonde M; Lewis MA; Boon R; Spruance SL;
    J Am Dent Assoc; 2002 Mar; 133(3):303-9. PubMed ID: 11934185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for antiviral-agent-resistant herpes simplex virus in the general population with recurrent herpes labialis.
    Bacon TH; Boon RJ; Schultz M; Hodges-Savola C
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3042-4. PubMed ID: 12183267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aciclovir + hydrocortisone. Herpes labialis: a topical antiviral drug perhaps, but not a steroid.
    Prescrire Int; 2011 Sep; 20(119):205-7. PubMed ID: 21954513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials.
    Spruance SL; Nett R; Marbury T; Wolff R; Johnson J; Spaulding T
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2238-43. PubMed ID: 12069980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent herpes simplex labialis: selected therapeutic options.
    Raborn GW; Grace MG
    J Can Dent Assoc; 2003 Sep; 69(8):498-503. PubMed ID: 12954137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of herpes simplex virus isolates to nucleoside analogues and the proportion of nucleoside-resistant variants after repeated topical application of penciclovir to recurrent herpes labialis.
    Shin YK; Weinberg A; Spruance S; Bernard M; Bacon TH; Boon RJ; Levin MJ
    J Infect Dis; 2003 Apr; 187(8):1241-5. PubMed ID: 12696003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosanol: a topical antiviral for herpes labialis.
    Leung DT; Sacks SL
    Expert Opin Pharmacother; 2004 Dec; 5(12):2567-71. PubMed ID: 15571473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group.
    Boon R; Goodman JJ; Martinez J; Marks GL; Gamble M; Welch C
    Clin Ther; 2000 Jan; 22(1):76-90. PubMed ID: 10688392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.